Evidence map›Paper›PMID 42620529›Full record

ArticleFrontiers in cellular and infection microbiology2026

Genetic determinants of metabolic-inflammatory dysregulation and machine learning prediction of COVID-19.

Larysa Sydorchuk, Maksym Sokolenko, Ruslan Sydorchuk, Alina Sokolenko, Iryna Kamyshna, Ludmila Sokolenko, Petro Moroz, Andrii Sydorchuk, Oleksandr Sokolenko, Iryna Halabitska and 2 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Larysa SydorchukDepartment of Family Medicine, Bukovinian State Medical University, Chernivtsi, Ukraine.
Maksym SokolenkoDepartment of Infectious Diseases and Epidemiology, Bukovinian State Medical University, Chernivtsi, Ukraine.
Ruslan SydorchukDepartment of General Surgery, Bukovinian State Medical University, Chernivtsi, Ukraine.
Alina SokolenkoDepartment of Family Medicine, Bukovinian State Medical University, Chernivtsi, Ukraine.
Iryna KamyshnaDepartment of Medical Rehabilitation, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Ludmila SokolenkoDepartment of Medical and Biological Fundamentals of Physical Culture, Pavlo Tychyna Uman State Pedagogical University, Uman, Ukraine.
Petro MorozDepartment of Surgery No1, Bukovinian State Medical University, Chernivtsi, Ukraine.
Andrii SydorchukDonauklinik, Neu Ulm, Germany.
Oleksandr SokolenkoBukovinian State Medical University, Chernivtsi, Ukraine.
Iryna HalabitskaDepartment of Therapy and Family Medicine, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Pavlo PetakhDepartment of Biochemistry and Pharmacology, Uzhhorod National University, Uzhhorod, Ukraine.
Oleksandr KamyshnyiDepartment of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to identify genetic variations that influence the metabolic-inflammatory profile of coronavirus disease and to evaluate the performance of modern machine learning models for the classification and prediction of COVID-19 severity. Real-time polymerase chain reaction was used to genotype the polymorphism of FGB (rs1800790), NOS3 (rs2070744) and TMPRSS2 (rs12329760) genes. Model performance was assessed using Accuracy and AUC-ROC, with a focus on maximizing AUC-ROC to ensure optimal discrimination, and SHAP analysis. Optimal hyperparameters for each model were defined as those yielding the highest mean AUC-ROC value during 5-fold cross-validation. COVID-19 severity is strongly associated with a pronounced pro-inflammatory and pro-endothelial activation profile, characterized by significantly elevated transmembrane serine protease 2 (TMPRSS2), endothelin-1 (ET-1), interleukin-6 (IL-6) and procalcitonin (PCT) levels, together with marked metabolic dysregulation. Genetic variations contribute to inter-individual differences in biomarker expression, with specific allelic variants modulating inflammatory intensity and endothelial dysfunction. In particular, the FGB rs1800790 A-allele and eNOS rs2070744 ТТ-genotype are associated with a more pronounced inflammatory response and endothelial dysfunction, while rs12329760 TMPRSS2 variants show weaker but detectable modulatory effects with higher transmembrane serine protease 2 value in T-allele moderate-severe COVID-19 patients. Ensemble methods such as ExtraTreesClassifier (Accuracy: 0.974 ± 0.022) and RandomForestClassifier (Accuracy: 0.960 ± 0.035) demonstrated the highest ROC curves approaching, confirming their encouraging performance in predicting COVID-19 severity. Simpler models, including BernoulliNB (Accuracy: 0.956 ± 0.037) and DecisionTreeClassifier (Accuracy: 0.938 ± 0.043), also showed high classification quality. Analysis of misclassification patterns revealed that ExtraTreesClassifier, HistGradientBoostingClassifier, BaggingClassifier, and GradientBoostingClassifier made no errors across any class. The poorest performance was observed with LinearDiscriminantAnalysis, which generated 11 misclassifications, followed by CalibratedClassifierCV, and LogisticRegressionCV. External validation of the obtained results in larger multicentre cohorts is essential before clinical implementation.

Indexed as

COVID-19Machine LearningBiomarkersGenetic Predisposition to DiseaseGenotypeHumansInflammationNitric Oxide Synthase Type IIIPolymorphism, Single NucleotidePredictive Learning ModelsROC CurveSARS-CoV-2Serine EndopeptidasesSeverity of Illness IndexBiomarkersNitric Oxide Synthase Type IIINOS3 protein, humanSerine EndopeptidasesTMPRSS2 protein, humanCOVID-19FGB (rs1800790)genes polymorphisminflammationmachine-learning modelsmetabolismNOS3 (rs2070744)TMPRSS2 (rs12329760)

Identifiers

PMID42620529
PMCPMC13485526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.